Patents Assigned to Nima Acquisition, LLC
  • Patent number: 12061191
    Abstract: A system and method for detecting harmful substances within a consumable sample comprising: receiving a consumable sample at a first chamber of a test container; transforming the consumable sample into a homogenized sample upon processing of the consumable sample; delivering the homogenized sample to a second chamber of the test container, wherein the second chamber is configured to receive the homogenized sample comprises an outlet port; mixing the homogenized sample with a process reagent within the second chamber, thereby producing a dispersion; transmitting a volume of the dispersion to an analysis chamber, of the test container, configured to position a detection substrate proximal the port of the second chamber and comprising a detection window that enables detection of presence of the allergen; and detecting presence of the allergen within the consumable sample by way of an optical sensor configured to detect signals indicative of the allergen through the detection window.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: August 13, 2024
    Assignee: Nima Acquisition, LLC
    Inventors: Scott Sundvor, Steven Portela, Jonathan Ward, John Walton, Jonathan William Kiel, Jeffrey Mekler, Shireen Yates, Jacob Mooney
  • Patent number: 12044678
    Abstract: A self-contained apparatus and methods for detecting the presence of any specified substance in any medium. A sample of the medium is placed in a capsule, along with a solvent and a sensor configured to test for a target analyte. The solvent comes into contact with the medium in the capsule, and the capsule is agitated to create a dispersion in the solvent of a portion of any target analyte present in the medium. A release mechanism configured to cause conduction of the dispersion to the sensor, so that the sensor produces an indication of presence of the target analyte if the target analyte is present in the medium. The apparatus uses a disposable capsule where the medium in question is placed and the disposable capsule is placed inside a reader and analyzed for presence of the harmful substance.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: July 23, 2024
    Assignee: Nima Acquisition, LLC
    Inventors: Scott Sundvor, John Paul Walton, Jonathan William Kiel, Jeffrey Mekler, Shireen Taleghani, Jacob Mooney
  • Patent number: 12031979
    Abstract: A system and method includes a test container for detecting a target substance in a consumable sample, where the test container includes a test container body defining a test container top, a test container bottom opposing the test container top, a first chamber proximal the test container top, and a second chamber proximal the test container bottom, a magnetic diaphragm situated between the first chamber and the second chamber, the magnetic diaphragm obstructing flow of the consumable sample, and the magnetic diaphragm including a magnetic element embedded in the magnetic diaphragm, and a driving element geometrically complementary to the first chamber, the driving element including a consumable sample grinding feature protruding from a surface of the driving element.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: July 9, 2024
    Assignee: Nima Acquisition, LLC
    Inventors: Scott Sundvor, Steven Portela, Jonathan Ward, John Walton, Jonathan William Kiel, Jeffrey Mekler, Shireen Yates, Jacob Mooney, Dane Weitmann, Joseph Horrell
  • Patent number: 11879007
    Abstract: The present invention provides anti-gliadin antibodies and antibody fragments, and polypeptides encoding the antibodies or fragment. Also disclosed are methods and Kits for the use of such antibodies, fragments, or polypeptides in detection of gliadin. Further provided are heavy chain and light chain variable sequences and associated sequences of complementarity-determining regions (CDRs).
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: January 23, 2024
    Assignee: Nima Acquisition, LLC
    Inventors: Jingqing Zhang, Shireen Taleghani Yates, Scott Erik Sundvor, Alim Seit-Nebi
  • Patent number: 11422130
    Abstract: A method includes capturing a signal of a detection substrate exposed to a sample containing a target substance; determining that the detection substrate is in a testable state; and generating an assessment of the presence of the target substance in the sample.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: August 23, 2022
    Assignee: Nima Acquisition, LLC
    Inventors: Scott Sundvor, Ian Wallhead, Joseph Horrell, John Artiuch, Dane Weitmann, Stephen Wilson, Steven Portela, Jingqing Zhang, Francisco Dias Lourenco
  • Patent number: 11214612
    Abstract: The present invention provides anti-gliadin antibodies and antibody fragments, and polypeptides encoding the antibodies or fragment. Also disclosed are methods and Kits for the use of such antibodies, fragments, or polypeptides in detection of gliadin. Further provided are heavy chain and light chain variable sequences and associated sequences of complementarity-determining regions (CDRs).
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: January 4, 2022
    Assignee: Nima Acquisition, LLC
    Inventors: Jingqing Zhang, Shireen Taleghani Yates, Scott Erik Sundvor, Alim Seit-Nebi
  • Patent number: 10837959
    Abstract: A system and method for detecting harmful substances within a consumable sample comprising: receiving a consumable sample at a first chamber of a test container; transforming the consumable sample into a homogenized sample upon processing of the consumable sample; delivering the homogenized sample to a second chamber of the test container, wherein the second chamber is configured to receive the homogenized sample comprises an outlet port; mixing the homogenized sample with a process reagent within the second chamber, thereby producing a dispersion; transmitting a volume of the dispersion to an analysis chamber, of the test container, configured to position a detection substrate proximal the port of the second chamber and comprising a detection window that enables detection of presence of the allergen; and detecting presence of the allergen within the consumable sample by way of an optical sensor configured to detect signals indicative of the allergen through the detection window.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: November 17, 2020
    Assignee: Nima Acquisition, LLC
    Inventors: Scott Sundvor, Steven Portela, Jonathan Ward, John Walton, Jonathan William Kiel, Jeffrey Mekler, Shireen Yates, Jacob Mooney